Over the past weeks, we’ve introduced four additional innovators at the forefront of cancer:
ONCO-LIQ – Cancer detection through routine blood testing
TELEXOS – Improved cancer diagnostics through detection of circulating tumor cells in blood
BETAGLUE – Treatment for cancer tumor margins to ensure eradication
INHERET – Self-administered genetic risk profiling
We want to invite you to help us determine which innovation is more important to support, and possibly invest in.
Would you take a few minutes to watch the recap video below and let us know which of these is most important to support by clicking here to take our very short survey?